Stock fact sheet · data as of
Universe Pharmaceuticals Inc. (UPC): fair value, margin of safety and Wheel Score
Ticker symbol UPC · Healthcare · Drug Manufacturers - Specialty & Generic · China · Class A ordinary shares · Speculative
UPC is Universe Pharmaceuticals Inc.'s Class A ordinary shares. The classes own the same business, share the same earnings report and trade within a few cents of each other; what differs is mainly the vote each share carries - the company's annual report sets out the voting rights.
Is UPC undervalued?
Universe Pharmaceuticals Inc. (UPC) closed at 1.47 on 5 Nov 2026. The GLS average fair value - the simple average of the 1 valuation models that produced a positive number - is 7,264.87, which puts the price 100% below it. 1 of the 1 models value the shares above the current price. A gap this wide is rare in our universe of ~7,400 US stocks and is exactly what the Value part of the Wheel Score rewards; it is also where the question "why is it this cheap?" matters most.
Only 1 of the nine models produced a value (DCF); the others need a dividend, positive free cash flow or positive book value the company does not have yet, so the average rests on a narrow base.
The nightly engine files UPC under Speculative - it is losing money or its Piotroski health score is 3 or lower - which caps its Wheel Score at 45 and keeps it out of the Sunday Scan.
Nine valuation models for UPC
Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.
| Model | Value | vs price | What it measures |
|---|---|---|---|
| DCF | 7,264.87 | +494109% | Present value of the projected free cash flows, discounted at the cost of capital |
| Graham Number | - | - | The most a defensive investor pays for the earnings and book value per share; no value tonight |
| Graham Growth | - | - | Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields; no value tonight |
| Lynch | - | - | EPS × the earnings growth rate (PEG of 1), growth capped at 25%; no value tonight |
| GLS Growth | - | - | EPS compounded ten years at the blended growth rate, discounted back at 15% a year; no value tonight |
| 10 Cap | - | - | Owner's earnings (operating cash flow less maintenance capex) capitalised at 10%; no value tonight |
| Payback Time | - | - | Eight years of compounded free cash flow: the price at which the business pays for itself; no value tonight |
| DDM | - | - | Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend; no value tonight |
| EPV | - | - | Earnings power value: current EPS capitalised at 9% with no growth; no value tonight |
| Zombie (liquidation) | 64.00 | +4253% | Current assets less all liabilities, per share: the balance-sheet floor. Not in the average |
| Wall St target | 0.0000 | -100% | Analysts' average 12-month price target. Not in the average |
Quality and financial health
Financial health is weak: UPC passes 2 of the nine Piotroski tests. Our scans drop the stock at the health filter; a low score is often the reason a stock looks cheap on the valuation models. The GLS Moat score is 5.1 out of 10: a record that is solid on some of the four parts the score weighs (returns on capital, pricing power, lasting growth, balance sheet) and weaker on others.
Returns on capital are thin or negative - ROIC -5.6%, ROE -6.5%, ROA -5.3% - with debt at 0.16 times equity and negative free cash flow.
Universe Pharmaceuticals Inc. pays no dividend, so the DDM model does not apply and a covered-call holder earns only the premium and any price gain.
Institutional ownership scores 1/10, insider activity 5/10 and Congressional trading 5/10 on the GLS smart-money scales.
| Piotroski F-score | 2 / 9 | ROIC | -5.6% |
|---|---|---|---|
| GLS Moat | 5.1 / 10 | ROE | -6.5% |
| Debt / equity | 0.16 | ROA | -5.3% |
| Free-cash-flow yield | -1334.4% | Payout ratio | 0% |
| Institutions | 1 / 10 | Insiders · Congress | 5 · 5 / 10 |
Wheel Score 26: No options
UPC has no listed options in the nightly snapshot, so there is nothing to sell and the stock cannot be wheeled however good the business. It fails the first Wheel Trade Filter (options that actually trade), so the score stays under 70 and is shown as "No options" (26 here). The valuation and quality numbers still apply to owning the shares outright.
Volume runs at 41k shares a day on a market cap of $929K, with a beta of 1.85 - a high beta, so the stock tends to move more than the market and a strike can be gapped through; the Stability part of the Wheel Score rates that weak.
| Filter | Wheel Trade Filter | Result | Detail |
|---|---|---|---|
| 1 | Options that actually trade | Fails | no listed options |
| 2 | A real business, not a gamble | Fails | speculative (a loss, or a weak Piotroski score) |
| 3 | Below fair value | Passes | Trading below the nine-model average fair value (margin of safety above 0) |
| 4 | Financially healthy | Fails | Piotroski 2/9 (under 6) |
| 5 | Can repay its debt | Passes | Long-term debt repaid from 3 years of operating cash flow or less (6 for real estate and utilities; banks and insurers are not judged on it) |
| 6 | No serious red flags | Passes | Red Flags score 60 or more out of 100 (earnings, margins, debt, analysts, filings and price checked the same way for every stock) |
| 7 | A premium worth selling | Fails | no implied volatility |
| 8 | Big enough | Fails | market cap $1M (under $1.0B) |
| 9 | Not a penny stock | Fails | price 1.47 (under $5) |
| How it ranks | Rating | From | |
|---|---|---|---|
| Value | Strong | 100% below fair value | |
| Premium | Weak | no option data | |
| Moat | Fair | moat 5.1/10 | |
| Health | Weak | Piotroski 2/9 | |
| Red Flags | Fair | not scored yet - half marks | |
| Option trading | Weak | no option volume data | |
| Stability | Weak | beta 1.85, $1M company |
The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls: a stock must pass all 9 Wheel Trade Filters to score 70, and the score then ranks the ones that pass; the Sunday Scan is the top 10. It is updated nightly and is not a recommendation. How the Wheel Score works · the walkthrough lesson shows how it fits into a trade, start to finish.
Upcoming events
No upcoming earnings date is recorded for UPC in the nightly calendar.
Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.
Similar stocks in Drug Manufacturers - Specialty & Generic
The 12 companies below are the closest to Universe Pharmaceuticals Inc. by market cap within the Drug Manufacturers - Specialty & Generic industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.
| Stock | Close | Fair value | MoS | Wheel | Mkt cap |
|---|---|---|---|---|---|
| RDHL RedHill Biopharma Ltd. | 0.4220 | - | - | 8No options | $1M |
| PCYN Procyon Corporation | 0.1800 | 0.2057 | +12% | 19No options | $1M |
| IMCC IM Cannabis Corp. | 0.7168 | 1.33 | +46% | 24No options | $433K |
| AKAN Akanda Corp. | 0.9998 | - | - | 9No options | $2M |
| GELS Gelteq Limited Ordinary Shares | 0.4611 | - | - | 12No options | $4M |
| YCBD cbdMD, Inc. | 0.4060 | - | - | 8No options | $5M |
| SNOA Sonoma Pharmaceuticals, Inc. | 1.11 | - | - | 13No options | $5M |
| SBFM Sunshine Biopharma, Inc. | 2.65 | - | - | 10No options | $6M |
| CABR Caring Brands, Inc. | 0.9000 | 0.1461 | -516% | 15No options | $8M |
| INM InMed Pharmaceuticals Inc. | 1.75 | - | - | 11No options | $10M |
| EGRX Eagle Pharmaceuticals, Inc. | 0.9500 | 62.37 | +98% | 32No options | $12M |
| OPTH Optimi Health Corp. | 2.21 | - | - | 11No options | $13M |
Scan the whole market the same way
A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the top 10 stocks that pass all 9 Wheel Trade Filters, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.
Start free See the Sunday ScanQuestions about UPC
What kind of share is UPC?
UPC is Universe Pharmaceuticals Inc.'s Class A ordinary shares. The classes own the same business, share the same earnings report and trade within a few cents of each other; what differs is mainly the vote each share carries - the company's annual report sets out the voting rights.
Is UPC undervalued right now?
By the GLS models, yes: at 1.47 the stock is 100% below the average fair value of 7,264.87 (data as of 5 Nov 2026). Whether the discount is deserved is the question to research next.
What is the Wheel Score of UPC and what does it mean?
UPC has no listed options in our nightly snapshot, so it cannot be wheeled; it fails the first Wheel Trade Filter (options that actually trade), stays under 70 and is shown as "No options".
What is the GLS fair value for UPC?
7,264.87 per share as of 5 Nov 2026 - the simple average of the 1 valuation models (out of nine: DCF, Graham Number, Graham Growth, Lynch, GLS Growth, 10 Cap, Payback Time, DDM and EPV) that produced a positive value. The models run every night on the latest filings; the Quote page lets you switch any of them off and add a margin of safety of your own.
When does Universe Pharmaceuticals Inc. report earnings next?
No upcoming earnings date is recorded for UPC in our calendar as of 5 Nov 2026; the Calendars page is refreshed every morning.
Does UPC have listed options, and how liquid are they?
No. The nightly options snapshot found no listed contracts on UPC, so the wheel strategy cannot be run on it and the Wheel Score stays under 70.